BACKGROUND AND PURPOSEImpulsivity is a core symptom in many neuropsychiatric disorders. The main objective of this study was to evaluate the effects of topiramate and pregabalin on the modulation of different impulsivity dimensions in DBA/2 mice.
EXPERIMENTAL APPROACHThe effects of acute and chronic administration of pregabalin (10, 20 and 40 mg·kg -1 ) and topiramate (12.5, 25 and 50 mg·kg -1 ) were evaluated in the light-dark box (LDB), hole board test (HBT) and delayed reinforcement task (DRT). a2A-Adrenoceptor, D2-receptor and TH gene expression were evaluated by real-time PCR in the prefrontal cortex (PFC), accumbens (ACC) and ventral tegmental area (VTA), respectively.
KEY RESULTSAcute pregabalin administration showed a clear anxiolytic-like effect (LDB) but did not modify novelty-seeking behaviour (HBT). In contrast, topiramate produced an anxiolytic effect only at the highest dose, whereas it reduced novelty seeking at all doses tested. In the DRT, acute pregabalin had no effect, whereas topiramate only reduced motor impulsivity. Chronically, pregabalin significantly increased motor impulsivity and topiramate diminished cognitive impulsivity. Pregabalin decreased a2A-adrenoceptor and D2-receptor gene expression in the PFC and ACC, respectively, and increased TH in the VTA. In contrast, chronic administration of topiramate increased a2A-adrenoceptor and D2-receptor gene expression in the PFC and ACC, respectively, and also increased TH in the VTA.
CONCLUSIONS AND IMPLICATIONSThese results suggest that the usefulness of pregabalin in impulsivity-related disorders is related to its anxiolytic properties, whereas topiramate modulates impulsivity. These differences could be linked to their opposite effects on a2A-adrenoceptor and D2-receptor gene expression in the PFC and ACC, respectively.
AbbreviationsACC, accumbens nucleus; ADHD, attention-deficit hyperactivity disorder; AMPA, a-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid; D2-receptor, D2 dopamine receptor; DRT, delayed reinforcement task; HBT, hole board test; LDB, light-dark box; PFC, prefrontal cortex; VTA, ventral tegmental area BJP British Journal of Pharmacology DOI:10.1111DOI:10. /j.1476DOI:10. -5381.2012 British Journal of Pharmacology (2012)
IntroductionImpulsivity constitutes a complex and multidimensional personality trait (Evenden, 1999a,b) that can be studied in both humans and animals by a wide range of methods (Winstanley et al., 2006). Behavioural disinhibition (motor impulsivity), manifested by poor inhibitory control of pre-potent responses, and impulsive choice (cognitive impulsivity), which refers to the preference for smaller immediate rewards over larger delayed rewards, are the most representative dimensions (Dougherty et al., 2003;Otobe and Makino, 2004;Adriani et al., 2010). In addition, there are other behavioural dimensions such as novelty-seeking behaviour closely related to impulsivity (Petry, 2001;James et al., 2007;Evren et al., 2012). Although impulsivity is a normal behaviour in healthy humans allowing ...